Cannabis use and psychotic disorders in diverse settings in the Global South: findings from INTREPID II.

Journal: Psychological medicine

Volume: 53

Issue: 15

Year of Publication: 2023

Affiliated Institutions:  Department of Psychiatry, University of the West Indies, Saint Augustine, Trinidad. Social, Genetic and Developmental Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Centre for Global Mental Health, London School of Hygiene & Tropical Medicine, London, UK. Department of Psychiatry, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences and Substance Abuse, University of Ibadan, Ibadan, Nigeria. Department of Psychiatry, Schizophrenia Research Foundation, Chennai, India. Institute of Mental Health, Madras Medical College, Kilpauk, Chennai, India. National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK. Psychosis Studies Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Department of Psychiatry, Rajiv Gandhi General Hospital and Madras Medical College, Chennai, India. Department of Psychiatry, Chengelpet Medical College, Chengelpet, Tamil Nadu, India. Mental Health Research Group, College of Medicine and Health, University of Exeter, Exeter, UK. Department of Psychiatry, University of KwaZulu Natal, Durban, South Africa.

Abstract summary 

Cannabis use has been linked to psychotic disorders but this association has been primarily observed in the Global North. This study investigates patterns of cannabis use and associations with psychoses in three Global South (regions within Latin America, Asia, Africa and Oceania) settings.Case-control study within the International Programme of Research on Psychotic Disorders (INTREPID) II conducted between May 2018 and September 2020. In each setting, we recruited over 200 individuals with an untreated psychosis and individually-matched controls (Kancheepuram India; Ibadan, Nigeria; northern Trinidad). Controls, with no past or current psychotic disorder, were individually-matched to cases by 5-year age group, sex and neighbourhood. Presence of psychotic disorder assessed using the Schedules for Clinical Assessment in Neuropsychiatry and cannabis exposure measured by the World Health Organisation Alcohol, Smoking and Substance Involvement Screening Test (ASSIST).Cases reported higher lifetime and frequent cannabis use than controls in each setting. In Trinidad, cannabis use was associated with increased odds of psychotic disorder: lifetime cannabis use (adj. OR 1.58, 95% CI 0.99-2.53); frequent cannabis use (adj. OR 1.99, 95% CI 1.10-3.60); cannabis dependency (as measured by high ASSIST score) (adj. OR 4.70, 95% CI 1.77-12.47), early age of first use (adj. OR 1.83, 95% CI 1.03-3.27). Cannabis use in the other two settings was too rare to examine associations.In line with previous studies, we found associations between cannabis use and the occurrence and age of onset of psychoses in Trinidad. These findings have implications for strategies for prevention of psychosis.

Authors & Co-authors:  Lee Pow Joni J Donald Casswina C di Forti Marta M Roberts Tessa T Weiss Helen A HA Ayinde Olatunde O John Sujit S Olley Bola B Ojagbemi Akin A Esponda Georgina Miguel GM Lam Joseph J Poornachandrika Paramasivam P Dazzan Paola P Gaughran Fiona F Kannan Palaniyandi Ponnusamy PP Sudhakar Selvaraju S Burns Jonathan J Chiliza Bonginkosi B Cohen Alex A Gureje Oye O Thara Rangaswamy R Murray Robin M RM Morgan Craig C Hutchinson Gerard G

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. (2002). Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. British Medical Journal, 325, 1212–1213.
Authors :  25
Identifiers
Doi : 10.1017/S0033291723000399
SSN : 1469-8978
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
cannabis;first-onset;global mental health;psychosis;schizophrenia
Study Design
Cross Sectional Study
Study Approach
Country of Study
Niger
Publication Country
England